ESketamine (INTRANASAL)
What is ESKETAMINE?
KETAMINE (INTRANASAL ESKETAMINE) Intranasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
**Treatment-resistant depression (TRD) in adults.
**Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. SPRAVATO (esketamine) is the first and only NMDA receptor antagonist approved for 2 subtypes of MDD in adult patients.
SPRAVATO treatment is covered by most insurance companies.
CONTACT THE OFFICE TODAY TO GET STARTED.
Click on the link below for more information regarding SPRAVATO
https://www.spravatohcp.com/sites/www.spravatohcp.com/files/SPRAVATO-Patient-Brochure.pdf?v=257568
https://www.spravatotreatmentcenter.com/sites/www.spravatotreatmentcenter.com/files/SPRAVATO_Dual_Indication_Product_Fact_Sheet.pdf?v=12
KETAMINE (INTRANASAL ESKETAMINE) Intranasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
**Treatment-resistant depression (TRD) in adults.
**Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. SPRAVATO (esketamine) is the first and only NMDA receptor antagonist approved for 2 subtypes of MDD in adult patients.
SPRAVATO treatment is covered by most insurance companies.
CONTACT THE OFFICE TODAY TO GET STARTED.
Click on the link below for more information regarding SPRAVATO
https://www.spravatohcp.com/sites/www.spravatohcp.com/files/SPRAVATO-Patient-Brochure.pdf?v=257568
https://www.spravatotreatmentcenter.com/sites/www.spravatotreatmentcenter.com/files/SPRAVATO_Dual_Indication_Product_Fact_Sheet.pdf?v=12